Martis Capital
Martis Capital is a California-headquartered private equity firm with offices in San Francisco and Washington, D.C., focused on middle-market investments in the United States. The firm concentrates on the healthcare sector and related industries, including consumer and wellness, products and diagnostics, information technology, services and outsourcing, and life sciences, aiming to partner with mid-sized healthcare companies to support growth and strategic development.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Oregon
HeartFlow
Convertible Note in 2025
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
HeartFlow
Series F in 2023
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
HeartFlow
Series E in 2017
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.